Herceptin®:: Breaking new ground

[1] STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J]. CELL, 1989, 57 (06) : 931 - 936

[2] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289

[3] Hotaling T. E., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P471

[4] P185HER2 MONOCLONAL-ANTIBODY HAS ANTIPROLIFERATIVE EFFECTS INVITRO AND SENSITIZES HUMAN-BREAST TUMOR-CELLS TO TUMOR NECROSIS FACTOR [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) : 1165 - 1172

[5] DIFFERENTIAL RESPONSES OF HUMAN TUMOR-CELL LINES TO ANTI-P185(HER2) MONOCLONAL-ANTIBODIES [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (04) : 255 - 263

[6] SINGLE-STEP INDUCTION OF MAMMARY ADENOCARCINOMA IN TRANSGENIC MICE BEARING THE ACTIVATED C-NEU ONCOGENE [J]. CELL, 1988, 54 (01) : 105 - 115

[7] The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy [J]. STEM CELLS, 1998, 16 (06) : 413 - 428

[8] THE NEU ONCOGENE - AN ERB-B-RELATED GENE ENCODING A 185,000-MR TUMOR-ANTIGEN [J]. NATURE, 1984, 312 (5994) : 513 - 516

[9] THE NEU GENE - AN ERBB-HOMOLOGOUS GENE DISTINCT FROM AND UNLINKED TO THE GENE ENCODING THE EGF RECEPTOR [J]. SCIENCE, 1985, 229 (4717) : 976 - 978

[10] HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J]. SCIENCE, 1987, 235 (4785) : 177 - 182

[1] STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J]. CELL, 1989, 57 (06) : 931 - 936

[2] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289

[3] Hotaling T. E., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P471

[4] P185HER2 MONOCLONAL-ANTIBODY HAS ANTIPROLIFERATIVE EFFECTS INVITRO AND SENSITIZES HUMAN-BREAST TUMOR-CELLS TO TUMOR NECROSIS FACTOR [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) : 1165 - 1172

[5] DIFFERENTIAL RESPONSES OF HUMAN TUMOR-CELL LINES TO ANTI-P185(HER2) MONOCLONAL-ANTIBODIES [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (04) : 255 - 263

[6] SINGLE-STEP INDUCTION OF MAMMARY ADENOCARCINOMA IN TRANSGENIC MICE BEARING THE ACTIVATED C-NEU ONCOGENE [J]. CELL, 1988, 54 (01) : 105 - 115

[7] The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy [J]. STEM CELLS, 1998, 16 (06) : 413 - 428

[8] THE NEU ONCOGENE - AN ERB-B-RELATED GENE ENCODING A 185,000-MR TUMOR-ANTIGEN [J]. NATURE, 1984, 312 (5994) : 513 - 516

[9] THE NEU GENE - AN ERBB-HOMOLOGOUS GENE DISTINCT FROM AND UNLINKED TO THE GENE ENCODING THE EGF RECEPTOR [J]. SCIENCE, 1985, 229 (4717) : 976 - 978

[10] HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J]. SCIENCE, 1987, 235 (4785) : 177 - 182